MRE11A, which has been suggested to be correlated with the progression and poor survival of prostate cancer, interacts with ATM, NBN, and BRCA1.12,15 Therefore, the loss-of-function in BRCA1 may affect MRE11A, affecting its progression rather than its development. Here, MRE11 is linked to prostate carcinoma.